Get the Stockscreener App
415.10
1.16%
4.60
Overview
News
Price History
Option Chain
Financials
Why HCA Down?
Discussions
Forecast
Dividend History
Hca Healthcare Inc stock is traded at $415.10, with a volume of 589.80K.
It is up +1.16% in the last 24 hours and up +11.59% over the past month.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
See More
Previous Close:
$410.50
Open:
$414.13
24h Volume:
589.80K
Relative Volume:
0.43
Market Cap:
$92.14B
Revenue:
$76.39B
Net Income/Loss:
$7.81B
P/E Ratio:
14.28
EPS:
29.0772
Net Cash Flow:
$7.93B
1W Performance:
+5.84%
1M Performance:
+11.59%
6M Performance:
-14.14%
1Y Performance:
+10.27%
1-Day Range:
$410.23
$417.25
1-Week Range:
$384.00
$417.25
52-Week Range:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Name
Hca Healthcare Inc
Sector
Industry
Phone
(615) 344-9551
Address
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
415.33 | 86.49B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
205.86 | 16.11B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
234.22 | 14.28B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.14B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
106.50 | 10.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-14-25 | Resumed | Goldman | Buy |
| Jul-28-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-16-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-29-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-25-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Nov-22-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-03-24 | Initiated | Morgan Stanley | Equal-Weight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-04-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-23 | Resumed | JP Morgan | Neutral |
| Jul-06-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-29-22 | Initiated | Wells Fargo | Equal Weight |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-24-21 | Initiated | UBS | Buy |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-13-21 | Resumed | Citigroup | Neutral |
| Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-14-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-06-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-10-19 | Upgrade | Goldman | Neutral → Buy |
| Apr-23-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Nov-16-18 | Initiated | UBS | Buy |
| Mar-23-18 | Resumed | Mizuho | Buy |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Jan-03-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Dec-20-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-12-17 | Upgrade | Citigroup | Neutral → Buy |
| Nov-30-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-06-17 | Reiterated | Citigroup | Neutral |
| Nov-01-17 | Reiterated | Mizuho | Buy |
| Jul-26-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-28-17 | Initiated | Argus | Buy |
View All
Hca Healthcare Inc Stock (HCA) Latest News
Can HCA's Gene Therapy Milestone Drive Long-Term Growth? - Yahoo Finance
HCA Healthcare focuses on hospital operations as investors watch US care demand - AD HOC NEWS
HCA Healthcare (HCA) Reports Promising Gene-Editing Therapy Study Results - Insider Monkey
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight - Investing.com
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight By Investing.com - Investing.com Canada
HCA Healthcare (HCA): 12 Best Value Stocks to Buy Right Now - Insider Monkey
VivaScore partners with HCA Healthcare UK to extend the impact of health screening through cutting-edge digital platform - EIN Presswire
HCA Healthcare (HCA) Expands Pediatric Gene Editing Access After Journal Study - Yahoo Finance
HCA Healthcare (HCA) Stock After Recent Slide And DCF Upside Potential - Yahoo Finance
HCA Healthcare outlook holds steady as consensus focuses on margins - AD HOC NEWS
How Removal From Key Russell Growth Indexes Will Impact HCA Healthcare (HCA) Investors - Yahoo Finance
HCA DCF Analysis: Intrinsic Value $765 vs Price $392 - GuruFocus
HCA Healthcare (HCA) Has a Hospital Cash-Flow Engine Bigger Than a Labor-Cost Debate - AlphaStreet
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children - BioSpace
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
HCA Announces Positive Results for Gene Editing Therapy in Child - GuruFocus
HCA Healthcare earnings calendar, NYSE-listed stock ahead of July report - AD HOC NEWS
HCA Healthcare announces New England Journal of Medicine study highlighting advances in CRISPR-based therapy for children - HCA Healthcare Today
HCA Healthcare Announces New England Journal of Medicine Study H - GuruFocus
HCA: Promising Gene-Editing Therapy Results for Pediatric Patien - GuruFocus
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children – Company Announcement - Financial Times
Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA) - simplywall.st
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 1000 Growth Benchmark - marketscreener.com
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell Top 200 Growth Benchmark - marketscreener.com
TD Cowen Cuts PT on HCA Healthcare (HCA) But Remains Bullish - Insider Monkey
Metropolis Capital Ltd Reduces Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare steadies after April earnings drop, shares track broader hospital peers - Ad-hoc-news.de
Michael Burry Loads Up On HCA Despite 23% YTD Fall — Calls Hospital Operator An ‘Insanely Efficient Compounder' - Stocktwits
Price to sales forward of HCA Healthcare, Inc. – NYSE:HCA - TradingView
Price to earnings forward of HCA Healthcare, Inc. – NYSE:HCA - TradingView
Price to earnings forward of HCA Healthcare Inc – TRADEGATE:2BH - TradingView
Price to book forward of HCA Healthcare Inc – TRADEGATE:2BH - TradingView
Enterprise value to revenue forward of HCA Healthcare, Inc. – NYSE:HCA - TradingView
Enterprise value to EBITDA forward of HCA Healthcare Inc – TRADEGATE:2BH - TradingView
HCA Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
The Technical Signals Behind (HCA) That Institutions Follow - Stock Traders Daily
HCA Healthcare guidance tweak and dividend focus, shares steady in a robust sector - Ad-hoc-news.de
HCA Florida Healthcare chief nursing officer discusses various emergency services in area - WEAR-TV
HCA FLORIDA JFK HOSPITAL EARNS STATUTORY TEACHING HOSPITAL DESIGNATION - Florida Hospital News and Healthcare Report
HCA Healthcare sets next earnings date, shares compared with Ensign Group - Ad-hoc-news.de
HCA Healthcare Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh - TradingView
2BH Forecast — Price Target — Prediction for 2027 - TradingView
TD Cowen Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $431 - Moomoo
OP Asset Management Ltd Makes New Investment in HCA Healthcare, Inc. $HCA - MarketBeat
Blue Trust Inc. Sells 4,560 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation - WZTV
DAI ‘Doubles Down’ on Hospice with HCA Healthcare Acquisition - Hospice News
DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home - Home Health Care News
How HCA Stock’s Quiet Compounding Changes The Growth Story - Trefis
HCA Healthcare Foundation supports Hope Lodge® communities serving cancer patients and their caregivers - HCA Healthcare Today
Hca Healthcare Inc Stock (HCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hca Healthcare Inc Stock (HCA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
1.26%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):